Progyny, Inc.

NasdaqGS PGNY

Progyny, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2024: 0.04

Progyny, Inc. Debt to Equity Ratio is 0.04 for the Trailing 12 Months (TTM) ending September 30, 2024, a 7.41% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Progyny, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.03, a 45.97% change year over year.
  • Progyny, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was 0.02, a -41.90% change year over year.
  • Progyny, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was 0.04.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
NasdaqGS: PGNY

Progyny, Inc.

CEO Mr. Peter Anevski CPA
IPO Date Oct. 25, 2019
Location United States
Headquarters 1359 Broadway
Employees 563
Sector Health Care
Industries
Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Similar companies

PRVA

Privia Health Group, Inc.

USD 21.00

1.25%

SLP

Simulations Plus, Inc.

USD 28.76

-0.48%

TDOC

Teladoc Health, Inc.

USD 9.36

-3.50%

EVH

Evolent Health, Inc.

USD 11.18

-9.77%

NRC

National Research Corporation

USD 16.93

-1.97%

CERT

Certara, Inc.

USD 10.74

-2.10%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

PHR

Phreesia, Inc.

USD 26.12

-1.69%

HSTM

HealthStream, Inc.

USD 31.47

1.68%

GDRX

GoodRx Holdings, Inc.

USD 4.15

-1.66%

HCAT

Health Catalyst, Inc.

USD 5.90

-9.09%

VEEV

Veeva Systems Inc.

USD 210.86

-0.93%

TXG

10x Genomics, Inc.

USD 15.44

-1.72%

StockViz Staff

January 15, 2025

Any question? Send us an email